Title |
Acetyl-DL-leucine improves gait variability in patients with cerebellar ataxia—a case series
|
---|---|
Published in |
Cerebellum & Ataxias, April 2016
|
DOI | 10.1186/s40673-016-0046-2 |
Pubmed ID | |
Authors |
Roman Schniepp, Michael Strupp, Max Wuehr, Klaus Jahn, Marianne Dieterich, Thomas Brandt, Katharina Feil |
Abstract |
Acetyl-DL-leucine is a modified amino acid that was observed to improve ataxic symptoms in patients with sporadic and hereditary forms of ataxia. Here, we investigated the effect of the treatment with Acetyl-DL-leucine on the walking stability of patients with cerebellar ataxia (10x SAOA, 2x MSA-C, 2x ADA, 1x CACNA-1A mutation, 2x SCA 2, 1x SCA 1). Treatment with Acetyl-DL-leucine (500 mg; 3-3-4) significantly improved the coefficient of variation of stride time in 14 out of 18 patients. Moreover, subjective ambulatory scores (FES-I and ABC) and the SARA scores were also improved under treatment. Further prospective studies are necessary to support these class III observational findings. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Science communicators (journalists, bloggers, editors) | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 23 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 5 | 22% |
Student > Ph. D. Student | 4 | 17% |
Researcher | 3 | 13% |
Student > Bachelor | 3 | 13% |
Other | 2 | 9% |
Other | 3 | 13% |
Unknown | 3 | 13% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 7 | 30% |
Nursing and Health Professions | 2 | 9% |
Neuroscience | 2 | 9% |
Agricultural and Biological Sciences | 2 | 9% |
Veterinary Science and Veterinary Medicine | 1 | 4% |
Other | 2 | 9% |
Unknown | 7 | 30% |